Prescribing Patterns and Tolerability of Mycophenolate and Azathioprine in Patients with Nonidiopathic Pulmonary Fibrosis Fibrotic Interstitial Lung Disease

Ann Am Thorac Soc. 2022 May;19(5):863-867. doi: 10.1513/AnnalsATS.202108-954RL.

Alyson W Wong^{1

2}, Yet H Khor^{3

4

5}, Kathryn Donohoe¹, Alessia Comes⁶, Veronica Marcoux⁷, Jolene H Fisher⁸, Kerri A Johannson⁹, Deborah Assayag¹⁰, Julie Morisset¹¹, Shane Shapera⁸, Nasreen Khalil¹, Charlene D Fell⁹, Helene Manganas¹¹, Gerard Cox¹², Teresa To^{8

13

14}, Andrea S Gershon^{8

13

14}, Nathan Hambly¹², Andrew J Halayko¹⁵, Mohsen Sadatsafavi¹, Pearce G Wilcox¹, Martin Kolb¹², Luca Richeldi⁶, Christopher J Ryerson^{1

2}

¹ University of British Columbia Vancouver, British Columbia, Canada.
² Centre for Heart Lung Innovation Vancouver, British Columbia, Canada.
³ Austin Health Heidelberg, Victoria, Australia.
⁴ Institute for Breathing and Sleep Heidelberg, Victoria, Australia.
⁵ University of Melbourne Melbourne, Victoria, Australia.
⁶ Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore Rome, Italy.
⁷ University of Saskatchewan Saskatoon, Saskatchewan, Canada.
⁸ University of Toronto Toronto, Ontario, Canada.
⁹ University of Calgary Calgary, Alberta, Canada.
¹⁰ McGill University Montreal, Québec, Canada.
¹¹ Centre Hospitalier de l'Université de Montréal Montreal, Québec, Canada.
¹² McMaster University Hamilton, Ontario, Canada.
¹³ The Hospital for Sick Children Toronto, Ontario, Canada.
¹⁴ ICES Toronto, Ontario, Canada.
¹⁵ University of Manitoba Winnipeg, Manitoba, Canada.

No abstract available

Publication types